These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 3876559)

  • 1. Phorbol ester induces a differential effect on the effector function of human allospecific cytotoxic T lymphocyte and natural killer clones.
    Bensussan A; Tourvieille B; Chen LK; Dausset J; Sasportes M
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6642-6. PubMed ID: 3876559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phorbol myristate acetate and in vitro T lymphocyte function. III. Selective impairment by PMA of lethal hit delivery by cloned CTL.
    Orosz CG; Roopenian DC
    Transplantation; 1985 Apr; 39(4):411-8. PubMed ID: 3157247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function.
    Hercend T; Meuer S; Brennan A; Edson MA; Acuto O; Reinherz EL; Schlossman SF; Ritz J
    J Exp Med; 1983 Nov; 158(5):1547-60. PubMed ID: 6355362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of murine susceptibility to tumor, parasite and bacterial challenge with altered cell-mediated immunity following systemic exposure to the tumor promoter phorbol myristate acetate.
    Murray MJ; Lauer LD; Luster MI; Luebke RW; Adams DO; Dean JH
    Int J Immunopharmacol; 1985; 7(4):491-500. PubMed ID: 3876295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal heterogeneity in the requirement for T3, T4, and T8 molecules in human cytolytic T lymphocyte function.
    Moretta A; Pantaleo G; Mingari MC; Moretta L; Cerottini JC
    J Exp Med; 1984 Mar; 159(3):921-34. PubMed ID: 6421984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for triggering of lysis by cytolytic T lymphocyte clones.
    Lancki DW; Weiss A; Fitch FW
    J Immunol; 1987 Jun; 138(11):3646-53. PubMed ID: 2953785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phorbol 12-myristate 13-acetate induces resistance of human melanoma cells to natural-killer- and lymphokine-activated-killer-mediated cytotoxicity.
    Correale P; Procopio A; Celio L; Caraglia M; Genua G; Coppola V; Pepe S; Normanno N; Vecchio I; Palmieri G
    Cancer Immunol Immunother; 1992; 34(4):272-8. PubMed ID: 1371427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD3 and phorbol myristate acetate regulation of MHC unrestricted T cell cytotoxicity. Lack of a requirement for CD3/T cell receptor complex expression during tumor cell lysis.
    Thiele DL; Patel SS; Lipsky PE
    J Immunol; 1988 May; 140(9):3253-60. PubMed ID: 2966209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective activation of helper and cytolytic T-cell functions of L3T4+ clones with either antireceptor antibody or phorbol ester and ionophore.
    Ju ST; DeKruyff RH; Dorf ME
    Cell Immunol; 1987 May; 106(2):260-72. PubMed ID: 2952285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
    Lancki DW; Kaper BP; Fitch FW
    J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a regulatory role of the T8 (CD8) antigen in antigen-specific and anti-T3-(CD3)-induced lytic activity of allospecific cytotoxic T lymphocyte clones.
    Van Seventer GA; Van Lier RA; Spits H; Ivanyi P; Melief CJ
    Eur J Immunol; 1986 Nov; 16(11):1363-71. PubMed ID: 2430810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional surface structures on human natural killer cells.
    Schmidt RE; Hercend T; Schlossman SF; Ritz J
    Klin Wochenschr; 1985 Dec; 63(23):1189-200. PubMed ID: 2418257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lymphokine that activates the cytolytic program of both cytotoxic T lymphocyte and natural killer clones.
    Milanese C; Siliciano RF; Schmidt RE; Ritz J; Richardson NE; Reinherz EL
    J Exp Med; 1986 Jun; 163(6):1583-8. PubMed ID: 3519831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-gamma,delta+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity.
    Koide J; Rivas A; Engleman EG
    J Immunol; 1989 Jun; 142(12):4161-8. PubMed ID: 2470816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of phorbol ester-mediated reduction of cloned T lymphocyte cytolysis by interleukin 2.
    Orosz CG; Scott JW; Gillis S; Finke JH
    J Immunol; 1985 Jan; 134(1):324-9. PubMed ID: 3871104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal analysis of T lymphocytes in spleens from patients with Hodgkin's disease. Frequent occurrence of unusual T4-positive cells which co-express cytolytic activity and production of interleukin-2.
    Romagnani S; Maggi E; Parronchi P; Macchia D; Del Prete GF; Rossi-Ferrini PL; Ricci M; Moretta L
    Int J Cancer; 1986 Mar; 37(3):343-9. PubMed ID: 3081452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of monoclonal antibodies against cell surface molecules associated with cytotoxic activity of natural and activated killer cells and cloned CTL lines.
    Spits H; Keizer G; Borst J; Terhorst C; Hekman A; de Vries JE
    Hybridoma; 1983; 2(4):423-37. PubMed ID: 6332061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.